Data at the End of a Long-Term Study Shows Shingrix Continues to Provide High Protection Against Shingles in Adults Aged 50 and Over for More than a Decade
End-of-trial data show 79.7% efficacy in participants aged 50 years and over, six to 11 years after vaccination [i] Vaccine efficacy remains high at 82.0%...
